Later Salivary Melatonin Onset Linked to ALS Progression
A study has found that a delayed onset of salivary melatonin is associated with the progression of Amyotrophic Lateral Sclerosis (ALS). This finding suggests that changes in melatonin timing could be linked to disease advancement in ALS patients, potentially offering new insights into disease mechanisms or progression markers.
EMJ·


